These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4749422

  • 1. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice.
    Yoshida O, Ertürk E, Bryan GT, Lower GM.
    Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
    Pai SH, Amaral L, Werthamer S, Zak FG.
    Invest Urol; 1974 Mar; 11(5):392-5. PubMed ID: 4815625
    [No Abstract] [Full Text] [Related]

  • 6. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E, Atassi SA, Yoshida O, Cohen SM, Price JM, Bryan GT.
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Pai SH, Amaral L, Werthamer S, Zak FG.
    Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
    [No Abstract] [Full Text] [Related]

  • 9. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
    Ertürk E, Cohen SM, Bryan GT.
    Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Production of urinary bladder carcinomas in male hamsters by N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide, N-(4-(5-nitro-2-furyl)-2-thiazolyl)-acetamide, or formic acid 2-(4-(5-nitro-2-furyl)-2-thiazolyl)hydrazide.
    Croft WA, Bryan GT.
    J Natl Cancer Inst; 1973 Sep; 51(3):941-9. PubMed ID: 4743562
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Ertürk E, Cohen SM, Price JM, Bryan GT.
    Cancer Res; 1969 Dec; 29(12):2219-28. PubMed ID: 5387262
    [No Abstract] [Full Text] [Related]

  • 16. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM, Murasaki G, Fukushima S, Greenfield RE.
    Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
    [No Abstract] [Full Text] [Related]

  • 17. Increased agglutinability of bladder cells by concanavalin A after administration of carcinogens.
    Kakizoe T, Komatsu H, Niijima T, Kawachi T, Sugimura T.
    Cancer Res; 1980 Jun; 40(6):2006-9. PubMed ID: 7371036
    [Abstract] [Full Text] [Related]

  • 18. The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer.
    Tiltman AJ.
    S Afr Med J; 1972 Mar 11; 46(11):293-4. PubMed ID: 5018148
    [No Abstract] [Full Text] [Related]

  • 19. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR, Spry LA, Zenser TV, Davis BB.
    Cancer Res; 1988 Jan 15; 48(2):304-9. PubMed ID: 3121171
    [Abstract] [Full Text] [Related]

  • 20. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.
    Ibrahiem EH, Nigam VN, Brailovsky CA, Madarnas P, Elhilali M.
    Cancer Res; 1983 Feb 15; 43(2):617-22. PubMed ID: 6848183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.